3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
9
Neoplasms
5
Anxiety Disorders
5
Pain
3
Lung Neoplasms
3
Depression
3
Sleep Initiation and Maintenance Disorders
2
Polycystic Ovary Syndrome
2
Obesity
2
Neuropathy, Painful
2
Fatigue
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Stress, Psychological
1
Squamous Intraepithelial Lesions
1
Smoking
1
Signs and Symptoms
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Papillomavirus Infections
1
Overweight
1
Ovarian Neoplasms
1
Neurobehavioral Manifestations
1
Multiple Myeloma
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma
1
Hot Flashes
1
Interventions
Paclitaxel
326
Carboplatin
318
Bevacizumab
167
Gemcitabine
106
pembrolizumab
100
liposomal doxorubicin
100
Cyclophosphamide
94
Topotecan
93
Cisplatin
89
olaparib
86
niraparib
60
Docetaxel
56
Taxes
52
Doxorubicin
50
Drug Therapy
42
fludarabine
39
Filgrastim
39
Nivolumab
37
Etoposide
32
Specimen Handling
31
Magnetic Resonance Spectroscopy
29
Immunoglobulin G
27
Disulfides
27
Peripheral Blood Stem Cell Transplantation
26
Albumin-Bound Paclitaxel
25
durvalumab
24
aldesleukin
24
Hyperthermic Intraperitoneal Chemotherapy
24
Oxaliplatin
23
Biopsy
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Ovarian Neoplasms
×
Mindfulness-Based Stress Reduction
×
Clear all
NCT02372864
2017-10-26
PURSUE
University Medical Center Groningen
Phase NA
Completed
66 enrolled